# Liposomal Amphotericin B in Invasive Aspergillosis With Hepatic Dysfunction

> **NCT07337720** · NA · NOT_YET_RECRUITING · sponsor: **Southeast University, China** · enrollment: 40 (estimated)

## Conditions studied

- Aspergillosis Invasive

## Interventions

- **DRUG:** LIposomal amphotericin B (L-AmB) treatment

## Key facts

- **NCT ID:** NCT07337720
- **Lead sponsor:** Southeast University, China
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-12-20
- **Primary completion:** 2026-12-20
- **Final completion:** 2027-03-20
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2026-01-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07337720

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07337720, "Liposomal Amphotericin B in Invasive Aspergillosis With Hepatic Dysfunction". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT07337720. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*